EFFECTS OF NALMEFENE, CG3703, TIRILAZAD, OR DOPAMINE ON CEREBRAL BLOOD-FLOW, OXYGEN DELIVERY, AND ELECTROENCEPHALOGRAPHIC ACTIVITY AFTER TRAUMATIC BRAIN INJURY AND HEMORRHAGE
Ds. Dewitt et al., EFFECTS OF NALMEFENE, CG3703, TIRILAZAD, OR DOPAMINE ON CEREBRAL BLOOD-FLOW, OXYGEN DELIVERY, AND ELECTROENCEPHALOGRAPHIC ACTIVITY AFTER TRAUMATIC BRAIN INJURY AND HEMORRHAGE, Journal of neurotrauma, 14(12), 1997, pp. 931-941
Hemorrhage after traumatic brain injury (TBI) in cats produces signifi
cant decreases in cerebral oxygen delivery (DcereO2) and electroenceph
alographic (EEG) activity. To determine whether effective treatments f
or the separate insults of TBI and hemorrhagic shock would also prove
effective after the clinically relevant combination of the two, we mea
sured the effects of a K-opiate antagonist (nalmefene), an inhibitor o
f lipid peroxidation (tirilazad), a thyrotropin-releasing hormone anal
og (CG3703), a clinically useful presser agent (dopamine) or a saline
placebo on cerebral blood flow (CBF), and EEG activity after TBI and m
ild hemorrhagic hypotension. Cats (n = 40, 8 per group) were anestheti
zed with 1.6% isoflurane in N2O:O-2 (70:30) and prepared for fluid-per
cussion TBI and microsphere measurements of CBF. Cats were randomized
to receive nalmefene (1 mg/kg), tirilazad (5 mg/kg), CG3703 (2 mg/kg),
dopamine (20 mu g.kg(-1) min(-1)) or a saline placebo (2 mi, 0.9% NaC
l). Animals were injured (2.2 atm), hemorrhaged to 70% of preinjury bl
ood volume, treated as just described and resuscitated with a volume o
f 10% hydroxyethyl starch equal to shed blood. CBF was determined and
EEG activity recorded before injury, after hemorrhage, and 0, 60, and
120 min after resuscitation (RO, R60, and R120). CBF increased signifi
cantly after resuscitation (RO) in the nalmefene-and CG3703-treated gr
oups. CBF did not differ significantly from baseline in any group at R
60 or R120. DcereO2 was significantly less than baseline in the saline
-, dopamine-, and tirilazad-treated groups at R60 and in the dopamine-
, tirilazad-, and CG3703-treated groups at R120. EEG activity remained
unchanged in the nalmefene-treated group but deteriorated significant
ly at R60 or R120 compared to baseline in the other groups. Nalmefene
and CG3703 preserved the hyperemic response to hemodilution (otherwise
antagonized by TBI), and nalmefene prevented the deterioration in Dce
reO2 and EEG activity that occurs after TBI and hemorrhage.